eCTD (electronic Common Technical Document) Publishing – is now the standard format required for presentation and submission of dossiers to the TGA for support of Prescription Medicine applications. This requires the use of special publishing software and skills and knowledge in the compilation of dossiers using this software. eCTD submissions have become mandatory for all submissions for prescription medicine and high-risk medicines from 1 May 2023. This means that sponsors need to consider preparing and submitting baselines for all of their previously submitted dossiers.
Regulatory Concepts has been submitting dossiers in eCTD format since 2019. We now have considerable expertise in the electronic submission of many different types of applications including new registrations, variations, notifications and baselines .
Whenever we receive a new product dossier for registration, we recommend that we undertake a Quality Review or GAP analysis of the dossier.
In addition to prescription medicine applications, we utilise the eCTD structure and publishing software for submission of OTC registrations, New Substance applications for Complementary Medicines as well as submissions to New Zealand.
The final published eCTD submission is compatible with all other eCTD publications as a standard format.